Naprod’s emerging market presence spreads across South-East Asia, Africa, Russia, CIS and Latin American countries. We are currently looking to expand our base by offering our Oncology and General formulations portfolio to a partner having a complimentary portfolio
Naprod is one of the pioneers in manufacturing of Lyophilized injections and OSD Oncology products and with our extensive expertise and capabilities offers competitive, high quality, custom end-to-end manufacturing services from API manufacturing through its group company Macchem, formulation development, analytical method development and validation, small scale & commercial scale production. The manufacturing facilities have been accredited by various international regulators including the ANVISA Brazil, INVIMA Colombia, PICS and other major approvals from Africa and CIS.
Contract Research and Development
Naprod has invested in expanding the entire spectrum of services to support projects from formulation to finished products. Labs are equipped for formulation and analytical development, including stability studies, method development and validation. Naprod believes in quick and timely delivery with QCD (Quality, Cost and Delivery) approach as per needs.